Testing a new eye drop to lower eye pressure in glaucoma

This trial is testing a new eye drop called TB0001 (pregabalin ophthalmic solution) to see if it can lower the pressure inside your eye as effectively as timolol, a standard glaucoma medication that many people already use. You would use the medication once daily for 28 days, and researchers would measure your eye pressure and monitor for any side effects to determine the best dose for future studies.

Glaucoma and high eye pressure damage the eye over time, and doctors need new treatment options that work well and are easy for patients to tolerate. This trial explores whether this new medication might offer patients another safe choice for managing their eye pressure.